Home  >  Investors

 

 

 

Investors

 

 

Build a smarter, safer and healthier future

Future

 

 

Outlook

Current

 

 

Business in Sweden

Sweden offers some of the best healthcare in the world and Swedish life science companies are global leaders in their field. Interest in commercial opportunities in this sector has never been higher. The Stockholm region has a complete ecosystem including recognised universities, incubators, science parks and testbeds.

Outlook by Sector

 

 

Promising investment opportunities

$390.7 billion by 2024


 

$1170 billion by 2021


 

$30.80 billion by 2020


 

$172.6 billion by 2022


 

Metabolic Diseases

$88.93 billion by 2025

Commercial

 

 

Life science projects and cross-disciplinary research

 

 

We invite partners from industry and academia to support ideas that can reshape the way we solve problems for major diseases.

 

 

 

© 2019 Nordic Joincells AB | This site uses cookies